Inflammatory Bowel Diseases

15th Congress of ECCO, February 12-15, 2020, Vienna/Austria

Pocket Guide Changes Page

Scientific Programme
15:30-17:10

Scientific Session 9: Basic Science: Big Data research
Sebastian Zeissig, Dresden, Germany
Laurence Egan, Galway, Ireland

16:00-16:10

55: OP32: Mincle signaling promotes intestinal mucosal inflammation through induction of macrophage pyroptosis and neutrophil chemotaxis in Crohn's Disease
CANCELLED

08:30-10:20

Scientific Session 10: Multidisciplinary cases
Dan Turner, Jerusalem, Israel
Marc Ferrante, Leuven, Belgium
Pierre Michetti, Lausanne, Switzerland
Yves Panis, Clichy, France
Frank Ruemmele, Paris, France

Digital Oral Presentation Session 2 -
Assessment of disease and therapy response 
18:00-18:06

DOP15: Transmural healing with vedolizumab in patients with active Crohn's Diesease
Shaji Adsul

18:06-18:12

DOP16: An evaluation of the exposure-efficacy relationship for subcutaneous vedolizumab maintenance treatment of Chron's Diesease: Pharmacokinetic findings from VISIBLE 2
Maria Rosario

Digital Oral Presentation Session 3 -
Improving care of IBD
17:30-17:36

DOP19: Real-world healthcare resource utilisation among patients with Inflammatory Bowel Disease administered vedolizumab for 6 months
Jason Rogers, New York, United States

17:54-18:00

DOP23: Endoscopic evaluation at one month after Ileocolic resection for Crohn's Disease predicts postoperative recurrence and is safe
CANCELLED

Digital Oral Presentation Session 6 -
New insights into pathogenesis of IBD
17:43-17:49

DOP49: Quantitative proteomics analysis of macrophages from Crohn's Disease patients and infected with adherent-invasive Escherichia coli
Anthony Buisson, Clermont-Ferrand, France

Digital Oral Presentation Session 8 -
Current and novel targets for IBD agents
17:37-17:43

DOP66: A CEACAM5 small peptide restores the suppressive activity of CD8 + T cells in patients with Crohn's Disease
Stefania Vetrano, Rozzano, Italy

17:49-17:55

DOP68: Thiomyristoyl Ameliorates Colitis by blocking the differentiation of Th17 Cells via STAT3/IL-6 Signal Pathway
CANCELLED

Digital Oral Presentation Session 10 -
Fighting the F's: Fat and fibrosis in IBD
18:13-18:19

DOP90: The role of Nlrp9b, a novel NLR member in regulating experimental colitis
CANCELLED

Educational Programme

6th Y-ECCO Basic Science Workshop

15:30-15:45

Whole blood TREM-1, marker of anti-TNF non-responsiveness in IBD
Bram Verstockt, Leuven, Belgium

14th N-ECCO Network Meeting

11:45-12:00

N01:Factors related to self-medication with corticosteroids, aminosalicylates or analgesics and reasons given by patients with Ulcerative Colitis from Spain

Sabela Fernandez, Madrid, Spain

No video selected.